Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Jun;113(6):769-74.
doi: 10.1007/s00702-005-0448-4. Epub 2006 May 12.

Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies

Affiliations
Review

Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies

M Fasano et al. J Neural Transm (Vienna). 2006 Jun.

Abstract

Human mesencephalic neuromelanin (NM) is characterized by an irregular, undefined structure, making its characterization by usual physico-chemical methodologies quite difficult. NM isolated from controls and from Parkinson's Disease (PD) patients was compared by high-resolution solid-state nuclear magnetic resonance (NMR). The pigment from PD patients appeared to be mainly composed of highly cross-linked, protease-resistant lipo-proteic material, with disappearance of melanin NMR resonances, suggesting melanin breakout due to oxidative stress conditions. Moreover, alpha-synuclein was detected in NM of PD patients and controls after cleavage of the melanin backbone under solubilizing conditions. NM stores iron ions as oxyhydroxide iron clusters containing thousands of iron atoms. Electron Paramagnetic Resonance (EPR) investigations and magnetic susceptibility measurements confirmed the occurrence of magnetic coupling among iron atoms, whereas in synthetic melanin the occurrence of isolated Fe(3+) ions was evident. NM from PD patients showed a lower total magnetization, possibly suggesting a progressive Fe migration from its storage environment (i.e., NM) to the cytosol.

PubMed Disclaimer

References

    1. J Neurochem. 2000 Dec;75(6):2583-9 - PubMed
    1. Nat Rev Drug Discov. 2004 Mar;3(3):205-14 - PubMed
    1. Biochim Biophys Acta. 1997 Jul 10;1361(1):49-58 - PubMed
    1. Science. 2001 Nov 9;294(5545):1346-9 - PubMed
    1. Pigment Cell Res. 1991 Dec;4(5-6):216-21 - PubMed

Publication types